Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Divi's Laboratories has informed that it enclosed the schedule of earnings conference call for the quarter and half year ended September 30, 2026, to be held on November 07, 2026.
The above information is a part of company’s filings submitted to BSE.